Aina Ulvmoen

  • Consultant; MD, PhD
  • +47 23 07 45 60
 

Publications 2024

Ulvmoen A, Greiff V, Bechensteen AG, Inngjerdingen M (2024)
NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia
J Leukoc Biol, 115 (2), 334-343
DOI 10.1093/jleuko/qiad112, PubMed 37738462

Publications 2023

Saidu NEB, Aarsund M, Sørensen E, Stensland M, Nyman TA, Ulvmoen A, Wu Y, Inngjerdingen M (2023)
Identifying a core protein signature of small extracellular vesicles derived from B-cell precursor acute lymphoblastic leukaemia
Scand J Immunol, 99 (3), e13341
DOI 10.1111/sji.13341, PubMed 38441169

Publications 2021

Thastrup M, Marquart HV, Levinsen M, Modvig S, Abrahamsson J, Albertsen BK, Frost BM, Harila-Saari A, Pesola J, Ulvmoen A, Wojcik DM, Taskinen M, Hoffmann M, Lausen B, Schmiegelow K, Nordic Society of Paediatric Haematology, Oncology (NOPHO) (2021)
Flow cytometric analysis of cerebrospinal fluid improves detection of leukaemic blasts in infants with acute lymphoblastic leukaemia
Br J Haematol, 195 (1), 119-122
DOI 10.1111/bjh.17769, PubMed 34396501

Publications 2020

Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, Frandsen TL, Harila-Saari A, Lähteenmäki PM, Niinimäki R, Pronk CJ, Ulvmoen A, Vaitkevičienė G, Taskinen M, Schmiegelow K, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2020)
Correction: Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study
Leukemia, 34 (10), 2822
DOI 10.1038/s41375-020-0821-1, PubMed 32269320

Publications 2019

Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, Frandsen TL, Harila-Saari A, Lähteenmäki PM, Niinimäki R, Pronk CJ, Ulvmoen A, Vaitkevičienė G, Taskinen M, Schmiegelow K, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2019)
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study
Leukemia, 34 (2), 336-346
DOI 10.1038/s41375-019-0570-1, PubMed 31534171

Publications 2017

Boieri M, Ulvmoen A, Sudworth A, Lendrem C, Collin M, Dickinson AM, Kveberg L, Inngjerdingen M (2017)
IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo
Oncoimmunology, 6 (3), e1274478
DOI 10.1080/2162402X.2016.1274478, PubMed 28405496

Publications 2016

Levinsen M, Marquart HV, Groth-Pedersen L, Abrahamsson J, Albertsen BK, Andersen MK, Frandsen TL, Harila-Saari A, Pronk C, Ulvmoen A, Vaitkevičienė G, Lähteenmäki PM, Niinimäki R, Taskinen M, Jeppesen M, Schmiegelow K, Nordic Society of Pediatric Hematology and Oncology (NOPHO) (2016)
Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia cases
Pediatr Blood Cancer, 63 (11), 1935-42
DOI 10.1002/pbc.26128, PubMed 27447373

Panagopoulos I, Torkildsen S, Gorunova L, Ulvmoen A, Tierens A, Zeller B, Heim S (2016)
RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report
Oncol Rep, 36 (5), 2481-2488
DOI 10.3892/or.2016.5119, PubMed 27667292

Publications 2012

Panagopoulos I, Micci F, Thorsen J, Haugom L, Tierens A, Ulvmoen A, Heim S (2012)
A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13)
Cancer Genet, 205 (12), 669-72
DOI 10.1016/j.cancergen.2012.10.004, PubMed 23181981

Page visits: 6312